Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by general360on Oct 06, 2020 11:20am
242 Views
Post# 31673364

RE:Wtf

RE:Wtf
NOT the NR i'm expecting to wake up to!

WTF is up w/ "The private placement is subject to satisfaction of a foreign government’s investment review, due diligence conditions, customary closing conditions for a transaction of this nature and receipt of all necessary regulatory and stock exchange approvals, and is expected to close on or before January 15, 2021."

when have we EVER had to wait for a foreign gov't review? we dont need approval from a foreign gov't, only from the TSX/exchange!  I dont think ive ever seen this before.  maybe Hepa is about to step over 50%?   this is a head scratcher fer sure.....and a really long closing period? i dont think weve ever seen this before either.  maybe we're gonna get some foreign sovereign wealth fund buy in...the saudi's are coming?!?

WTF good is raising money now, when we're broke, but it's not gonna close until Jan of 2021?!  does that mean we have enuf now to last until Jan, but this would fill the coffers from Jan until......... so we're not partnering now, at least through 2021?  hard to tell how much runway 13M buys us these days with everything in arrears...

boardroom games...i'm not amused....
Bullboard Posts